Status:
ACTIVE_NOT_RECRUITING
Arrhythmia in Hemodialysis Patients
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Arrythmia, Cardiac
Sudden Cardiac Death
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients receiving dialysis for kidney failure suffer from very high rates of sudden cardiac death due to abnormal heart rhythms and perfusion defects associated with HD treatment. It has previously b...
Detailed Description
This is an exploratory, single group, observational study involving patients recruited from the dialysis patient population of the London Health Science Centre (LHSC) Regional Renal Program. Recruited...
Eligibility Criteria
Inclusion
- No significant residual renal function (\<250ml of urine per day).
- Must be on hemodialysis for at least 3 months
- Age ≥18 years
- Able/willing to provide informed consent
Exclusion
- Presence of a pacemaker and implantable cardioverter defibrillator
- Prior diagnosis of chronic arrhythmia and/or are on anti-arrhythmic drugs
Key Trial Info
Start Date :
October 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04036695
Start Date
October 17 2019
End Date
December 30 2025
Last Update
February 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
London, Ontario, Canada, N6A 5A5
2
Kidney Care Centre
London, Ontario, Canada, N6K 1M6